These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 7908949

  • 1. Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain.
    Undie AS, Weinstock J, Sarau HM, Friedman E.
    J Neurochem; 1994 May; 62(5):2045-8. PubMed ID: 7908949
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of dopamine agonist-induced phosphoinositide hydrolysis by concomitant stimulation of cyclic AMP formation in brain slices.
    Undie AS, Friedman E.
    J Neurochem; 1994 Jul; 63(1):222-30. PubMed ID: 7911510
    [Abstract] [Full Text] [Related]

  • 3. Selective dopaminergic mechanism of dopamine and SKF38393 stimulation of inositol phosphate formation in rat brain.
    Undie AS, Friedman E.
    Eur J Pharmacol; 1992 Aug 03; 226(4):297-302. PubMed ID: 1327844
    [Abstract] [Full Text] [Related]

  • 4. D1-like dopaminergic activation of phosphoinositide hydrolysis is independent of D1A dopamine receptors: evidence from D1A knockout mice.
    Friedman E, Jin LQ, Cai GP, Hollon TR, Drago J, Sibley DR, Wang HY.
    Mol Pharmacol; 1997 Jan 03; 51(1):6-11. PubMed ID: 9016340
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain.
    Undie AS, Friedman E.
    J Pharmacol Exp Ther; 1990 Jun 03; 253(3):987-92. PubMed ID: 1972756
    [Abstract] [Full Text] [Related]

  • 7. Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum.
    Pifl C, Reither H, Hornykiewicz O.
    Eur J Pharmacol; 1991 Sep 17; 202(2):273-6. PubMed ID: 1839386
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum.
    Meschler JP, Howlett AC.
    Neuropharmacology; 2001 Jun 17; 40(7):918-26. PubMed ID: 11378162
    [Abstract] [Full Text] [Related]

  • 10. Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation.
    Wang HY, Undie AS, Friedman E.
    Mol Pharmacol; 1995 Dec 17; 48(6):988-94. PubMed ID: 8848015
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
    Deveney AM, Waddington JL.
    Br J Pharmacol; 1995 Oct 17; 116(3):2120-6. PubMed ID: 8640354
    [Abstract] [Full Text] [Related]

  • 12. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D, Osborn CV.
    Eur J Pharmacol; 2005 Dec 28; 528(1-3):88-94. PubMed ID: 16324697
    [Abstract] [Full Text] [Related]

  • 13. SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase C.
    Lee SM, Kant A, Blake D, Murthy V, Boyd K, Wyrick SJ, Mailman RB.
    Neuropharmacology; 2014 Nov 28; 86():145-54. PubMed ID: 24929112
    [Abstract] [Full Text] [Related]

  • 14. Dopaminergic behaviors and signal transduction mediated through adenylate cyclase and phospholipase C pathways.
    Undie AS, Berki AC, Beardsley K.
    Neuropharmacology; 2000 Nov 28; 39(1):75-87. PubMed ID: 10665821
    [Abstract] [Full Text] [Related]

  • 15. SKF83959 exhibits biochemical agonism by stimulating [(35)S]GTP gamma S binding and phosphoinositide hydrolysis in rat and monkey brain.
    Panchalingam S, Undie AS.
    Neuropharmacology; 2001 May 28; 40(6):826-37. PubMed ID: 11369036
    [Abstract] [Full Text] [Related]

  • 16. Further evidence against the coupling of dopamine receptors to phosphoinositide hydrolysis in rat striatum.
    Rubinstein JE, Hitzemann RJ.
    Biochem Pharmacol; 1990 Jun 15; 39(12):1965-70. PubMed ID: 1972328
    [Abstract] [Full Text] [Related]

  • 17. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors.
    Andringa G, Drukarch B, Leysen JE, Cools AR, Stoof JC.
    Eur J Pharmacol; 1999 Jan 01; 364(1):33-41. PubMed ID: 9920182
    [Abstract] [Full Text] [Related]

  • 18. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
    Hasegawa M, Adachi K, Nakamura S, Sato M, Waddington JL, Koshikawa N.
    Eur J Pharmacol; 2001 Jul 06; 423(2-3):171-8. PubMed ID: 11448482
    [Abstract] [Full Text] [Related]

  • 19. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):73-82. PubMed ID: 1321630
    [Abstract] [Full Text] [Related]

  • 20. Grooming and vacuous chewing induced by SK&F 83959, an agonist of dopamine 'D1-like' receptors that inhibits dopamine-sensitive adenylyl cyclase.
    Downes RP, Waddington JL.
    Eur J Pharmacol; 1993 Mar 30; 234(1):135-6. PubMed ID: 8097163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.